Login / Signup

Why Amyloid Is Still a Target for Alzheimer Disease Clinical Trials.

Eric McDade
Published in: Journal of the American Geriatrics Society (2019)
Keyphrases
  • clinical trial
  • mild cognitive impairment
  • phase ii
  • open label
  • phase iii